Jérémie Zerbit

1.4k total citations
10 papers, 154 citations indexed

About

Jérémie Zerbit is a scholar working on Oncology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jérémie Zerbit has authored 10 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jérémie Zerbit's work include COVID-19 Clinical Research Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Jérémie Zerbit is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Jérémie Zerbit collaborates with scholars based in France, Switzerland and United States. Jérémie Zerbit's co-authors include Rudy Birsen, Didier Bouscary, Justine Decroocq, Isabelle Madelaine, Éric Grignano, Nicolas Chapuis, Michaëla Fontenay, Olivier Kosmider, Simon Garinet and Jérôme Clerc and has published in prestigious journals such as Cancer Treatment Reviews, Thyroid and Viruses.

In The Last Decade

Jérémie Zerbit

9 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérémie Zerbit France 7 47 34 33 32 32 10 154
Myria Galazi United Kingdom 7 63 1.3× 49 1.4× 13 0.4× 57 1.8× 17 0.5× 19 190
Nalinie Joharatnam‐Hogan United Kingdom 10 107 2.3× 43 1.3× 27 0.8× 86 2.7× 16 0.5× 14 253
Mohammad M. AlAhmad United Arab Emirates 7 33 0.7× 28 0.8× 7 0.2× 11 0.3× 8 0.3× 25 166
Hsiao‐Ching Huang United States 9 59 1.3× 33 1.0× 36 1.1× 8 0.3× 8 0.3× 24 246
M. Wesley Milks United States 9 32 0.7× 26 0.8× 5 0.2× 33 1.0× 21 0.7× 23 244
Louise Nott Australia 6 48 1.0× 17 0.5× 9 0.3× 38 1.2× 9 0.3× 10 132
Scott Ramsey United States 6 48 1.0× 18 0.5× 7 0.2× 56 1.8× 12 0.4× 12 158
Sonar Soni Panigoro Indonesia 7 73 1.6× 77 2.3× 6 0.2× 18 0.6× 17 0.5× 47 197
Sherif Abouelnaga Egypt 6 28 0.6× 23 0.7× 10 0.3× 22 0.7× 3 0.1× 14 155

Countries citing papers authored by Jérémie Zerbit

Since Specialization
Citations

This map shows the geographic impact of Jérémie Zerbit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Zerbit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Zerbit more than expected).

Fields of papers citing papers by Jérémie Zerbit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérémie Zerbit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Zerbit. The network helps show where Jérémie Zerbit may publish in the future.

Co-authorship network of co-authors of Jérémie Zerbit

This figure shows the co-authorship network connecting the top 25 collaborators of Jérémie Zerbit. A scholar is included among the top collaborators of Jérémie Zerbit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémie Zerbit. Jérémie Zerbit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Decroocq, Justine, Laurent Chouchana, Vassilis Tsatsaris, et al.. (2024). Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study. The Lancet Haematology. 11(11). e850–e861. 2 indexed citations
2.
Ysebaert, Loïc, Stéphane Éderhy, Véronique Leblond, et al.. (2024). Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France. Clinical Lymphoma Myeloma & Leukemia. 25(3). e173–e181.
3.
Grignano, Éric, Jérémie Zerbit, Justine Decroocq, et al.. (2023). Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discovery. 9(1). 97–97. 38 indexed citations
4.
Zerbit, Jérémie, Antoine Meyer, Justine Decroocq, et al.. (2022). Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses. 14(11). 2377–2377. 15 indexed citations
5.
Groussin, Lionel, Fidéline Bonnet-Serrano, Béatrix Cochand‐Priollet, et al.. (2022). Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer. Thyroid. 32(5). 594–598. 35 indexed citations
6.
Zerbit, Jérémie, Marie Kroemer, Justine Decroocq, et al.. (2022). Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis. European Journal of Cancer Care. 31(6). e13753–e13753. 6 indexed citations
7.
Chouchana, Laurent, Inès Gana, Lucile Regard, et al.. (2020). Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients. Therapeutic Drug Monitoring. 43(1). 131–135. 9 indexed citations
8.
Slimano, Florian, Jérémie Zerbit, Audrey Thomas‐Schoemann, et al.. (2020). Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treatment Reviews. 88. 102063–102063. 33 indexed citations
9.
Zerbit, Jérémie, Sylvie Chevret, Sophie Bernard, et al.. (2020). Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study. Annals of Hematology. 99(7). 1615–1625. 13 indexed citations
10.
Zerbit, Jérémie, et al.. (2014). Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use. European Journal of Hospital Pharmacy. 22(2). 89–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myria Galazi Breakdown of academic impact, for papers by Nalinie Joharatnam‐Hogan Breakdown of academic impact, for papers by Mohammad M. AlAhmad Breakdown of academic impact, for papers by Hsiao‐Ching Huang Breakdown of academic impact, for papers by M. Wesley Milks Breakdown of academic impact, for papers by Louise Nott Breakdown of academic impact, for papers by Scott Ramsey Breakdown of academic impact, for papers by Sonar Soni Panigoro Breakdown of academic impact, for papers by Sherif Abouelnaga
Rankless by CCL
2026